August 18, 2026 11:17 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
BJP reshuffles top organisation seven months after Nitin Nabin's elevation | West Bengal STF arrests suspected aide of ISI 'agent' Rana Rauf in Kolkata | ‘Very hopeful’: Indian envoy Dinesh Trivedi breaks silence on PM Tarique Rahman’s proposed India visit | Shehzad Poonawalla doubles down on BJP exit, urges party to accept resignation | Tarapith tragedy: Seven pilgrims killed as hotel goes up in flames before dawn | Bengal STF nabs suspected aide of ISI 'agent' Rana Rauf in Kolkata | After SC rebuke, BCI chief apologises to NALSAR students over enrolment freeze row | Independence Day: PM Modi’s big youth pitch— AI training, free coaching amid exam row and job concerns | ‘Shakti Ki Saptadhara’: Modi reveals 7 pillars to power India’s next leap in his I-Day speech from Red Fort | West Bengal STF arrests 3 more suspected Pakistani spies in Cooch Behar

Jubilant Life Sciences receives ANDA approval for Levofloxacin Tablets

| | Jun 23, 2015, at 10:54 pm
New Delhi, June 23 (IBNS) Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Levofloxacin Tablets, 250mg and 500mg, the generic version of Levaquin Tablets (of Ortho-McNeil), which is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections, chronic bacterial prostatitis, urinary tract infections and inhalational anthrax.

The total market size for Levofloxacin Tablets as per IMS is $28 Million per annum.

As on Mar 31, Jubilant Life Sciences had a total of 806 filings for formulations of which 368 have been approved in various regions globally. This includes 72 ANDAs filed in the US, of which 38 have been approved and 46 Dossier filings in Europe.

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.